ABSTRACT The ExPortal of Streptococcus pyogenes is a focal microdomain of the cytoplasmic membrane that clusters the translocons of the general secretory pathway with accessory factors to facilitate the maturation of secreted polypeptides. While it is known that the ExPortal is enriched in anionic lipids, the mechanisms that organize the ExPortal are poorly understood. In the present study, we examined the role of the cell wall in organizing and maintaining the ExPortal. Removal of the cell wall resulted in a loss of ExPortal focal integrity accompanied by the circumferential redistribution of ExPortal lipid and protein components. A similar loss occurred upon treatment with gallidermin, a nonpermeabilizing lantibiotic that targets the lipid II precursor of peptidoglycan synthesis, and this treatment disrupted the secretion of several ExPortal substrates. Furthermore, several enzymes involved in the membrane-associated steps of lipid II synthesis, including MraY and MurN, were found to localize to a single discrete focus in the membrane that was coincident with the focal location of the secretory translocons and the anionic lipid microdomain. These data suggest that the ExPortal is associated with the site of peptidoglycan precursor synthesis and that peptidoglycan biogenesis influences ExPortal organization. These data add to an emerging literature indicating that cell wall biogenesis, cell division, and protein secretion are spatially coorganized processes.
oordination of the biogenesis of secreted proteins can present a significant challenge to Gram-positive bacteria. One problem is that because these bacteria lack a periplasmic space, they lack a specialized compartment that can facilitate the interaction of nascently secreted polypeptides with accessory folding and processing factors. One solution found in many streptococcal species is to cluster translocons and accessory factors together in a focal microdomain in the cytoplasmic membrane known as the ExPortal (1-3). However, the mechanisms underlying the organization of this organelle are still poorly understood.
The ExPortal has been most extensively studied in Streptococcus pyogenes, the causative agent of diseases that range from largely superficial infections of the skin and mucous membranes (impetigo, pharyngitis), to highly invasive diseases (necrotizing fasciitis) and serious postinfection sequelae (rheumatic fever, glomerulonephritis; reviewed in reference 4). The ability of S. pyogenes to cause disease depends on the secretion of an extensive network of virulence proteins (4, 5) . Since its genome lacks any alternative secretion system (6) , it relies on the general secretory pathway for protein export (for a review, see reference 7) .
One feature of the S. pyogenes ExPortal that may play a key role in organization is its asymmetric lipid content, enriched in anionic phospholipids (8) , that contributes to the retention of certain proteins at the ExPortal versus the peripheral membrane (2) . Among the proteins that are retained are several that function in the biogenesis of virulence proteins, including sortases and HtrA. The former are involved in the biogenesis of pili and the covalent attachment of proteins to the cell wall (1, 2, 9) , while the latter is involved in the maturation of several secreted proteins (10, 11) . Mutations that mislocalize HtrA or sortase reduce the efficiency of both pilus (2) and SpeB (11) biogenesis. In the case of sortase, mutations that reduce the density of positively charged residues on the cytoplasmic tail of its single transmembrane domain result in mislocalization (2) , indicating charge interactions with the anionic microdomain in ExPortal organization.
The importance of the anionic character of the ExPortal is further illustrated by its interaction with several cationic antimicrobial proteins (CAPs). These proteins preferentially bind to anionic lipids and have been found to target the S. pyogenes ExPortal at nonpermeablizing, sublethal concentrations. Binding then acts to disorganize the localization of anionic lipids, HtrA, and the SecA ATPase in the ExPortal microdomain (12) . Furthermore, disruption is associated with inhibition of the secretion of several toxins (12) , supporting a role for the ExPortal in the coordination of secretion-related events.
Interestingly, one of the CAPs revealed to interfere with ExPortal organization, human neutrophil peptide 1, has also been shown to target lipid II in bacterial membranes (13) . This molecule plays an essential role in cell wall synthesis and is responsible for linking the cytoplasmic synthesis of the peptidoglycan monomer unit to its extracytoplasmic polymerization reactions (reviewed in references 14 and 15). Many CAPs target lipid II to form pores that efficiently permeabilize the bacterial cell membrane (for a review, see reference 16). However, a subset including the lantibiotic gallidermin are not efficient at forming pores and promote lethality by disrupting cell wall synthesis (17) (18) (19) . These act through an alternative mechanism, sequestering lipid II into patches of the membrane away from the regions where peptidoglycan synthesis occurs (17) (18) (19) .
Lipid II is also the substrate for cell wall sorting, in which a protein secreted by the Sec pathway containing the appropriate sorting signal is covalently attached to the peptide moieties of lipid II by sortase. Subsequent transglycoslyation and transpeptidation reactions then incorporate this product into the maturing cell wall (reviewed in reference 20). Emerging evidence indicates that secretion and sorting of virulence factors are parts of a highly organized process coordinated with the site of de novo peptidoglycan synthesis (1, 2, 9, 21) . These data suggest that peptidoglycan biogenesis and ExPortal-mediated secretion may be spatially linked processes.
In the present study, we examined the relationships among the streptococcal cell wall, peptidoglycan synthesis, and the ExPortal. We report that the cell wall is required for maintenance of the proper localization of both lipid and protein components of the ExPortal. Furthermore, proteins responsible for the membraneassociated steps of lipid II synthesis localize to foci that coincide with the anionic lipid microdomain. Together, these data reveal an intimate association between cell wall synthesis and ExPortal organization.
RESULTS

Peptidoglycan is required for organization of the ExPortal anionic lipid microdomain.
To characterize the involvement of cell wall biogenesis in ExPortal organization, we first determined whether the cell wall is necessary to maintain ExPortal integrity. To that end, we examined the localization of anionic lipids in the cytoplasmic membrane in protoplasts devoid of extracellular peptidoglycan. Treatment with purified PlyC lysin of logarithmic and stationary-phase streptococcal cultures resuspended in either raffinose-or glycerol-supplemented medium removed detectable surface peptidoglycan from the majority of streptococci, as monitored by the breakdown of streptococcal chains into individual protoplasts and the absence of cell wall staining by fluorescent vancomycin (FL-vancomycin) or wheat germ agglutinin (WGA) (Fig. 1) . In treated cultures, the minority of cells that retained their cell wall, as evidenced by staining with FL-vancomycin, also displayed the focal staining pattern of labeled polymyxin B (Fig. 1A ) characteristic of cells from untreated cultures (Fig. 1C) (12) . However, protoplasting coincided with the redistribution of labeled polymyxin B from unique foci to a more uniform circumferential pattern, giving the protoplasts a "halo" appearance ( 
D)
. The circumferential labeling pattern of polymyxin B in protoplasts also resembled that of the neutral lipid-binding dye Nile Red (Fig. 1F) , showing that in the absence of cell wall peptidoglycan, the integrity of the anionic lipid microdomain of the ExPortal is lost and anionic lipids are uniformly distributed in the membrane, in a manner similar to that of neutral lipids in untreated cells (Fig. 1E ). The redistribution of anionic lipids was confirmed with the fluorescent dye 10-N-nonyl-acridine orange (NAO). In intact streptococci, NAO staining revealed the unique anionic lipid microdomains described previously ( Fig. 1G ) (8, 12) , whereas protoplasts displayed the same "halo" staining pattern observed with fluorescent polymyxin B (Fig. 1H) . It is unlikely that redistribution of polymyxin B and NAO in protoplasts is due to increased accessibility of the labeling agents to the cytoplasmic membrane, since cultures were washed to remove excess fluorescent label prior to protoplasting. Furthermore, redistribution of anionic lipids was not due to a perturbation of membrane integrity, as quantitation of polymyxin B-treated protoplasts with a fluorescent vital dye indicated that their membranes were not permeabilized (see Fig. S1 in the supplemental material). Peptidoglycan is required for focal localization of ExPortal proteins. Previous work has shown that localization of ExPortalassociated proteins such as SecA and HtrA coincided with the anionic lipid microdomain of the ExPortal (8, 11) and that disruption of the microdomain by CAPs resulted in redistribution of these proteins (12) . Examination of protoplasts by immunofluorescence microscopy revealed that removal of peptidoglycan led to a similar redistribution of HtrA from a focal ( Fig. 2A) to a circumferential (Fig. 2B ) pattern. The translocon ATPase SecA also redistributed from foci in intact cells (Fig. 2C ) to either multiple foci or a more uniform circumferential pattern in protoplasts (Fig. 2D) . Redistribution was not observed in the minor population of treated cells, where peptidoglycan removal was incomplete, as WGA-staining cells retained unique foci of both HtrA ( Fig. 2E ) and SecA (data not shown).
Gallidermin disrupts the ExPortal. The data above suggest that an intact cell wall is required for ExPortal organization. To examine the relationship between the ExPortal and the site of peptidoglycan synthesis, we first examined whether compounds that disrupt cell wall synthesis also affect ExPortal organization and function. The lantibiotic gallidermin binds lipid II and promotes lethality primarily by arresting cell wall synthesis by sequestering lipid II (17, 22, 23) . Consistent with prior reports (17, 23), gallidermin's inefficient pore-forming activity was reflected by the higher concentration required to compromise S. pyogenes membrane integrity compared to that of nisin, an efficient poreforming lantibiotic. Cell viability was lost at nisin concentrations of Ͼ0.5 M but was unaffected at 2.0 M gallidermin (see Fig. S2 in the supplemental material). Cultures were then treated with a nonlytic concentration of gallidermin (1.0 M), and several ExPortal-related phenotypes were monitored. Examination by fluorescence microscopy revealed that the typical focal staining pattern of a sublethal concentration of boron-dipyrromethene (BODIPY)-polymyxin B (Fig. 3A) was disrupted by treatment with a nonlytic concentration of gallidermin ( Fig. 3B ) and appeared similar to the pattern observed following exposure to ExPortal-disrupting amounts of polymyxin B (Fig. 3C) (12) . Treatment with gallidermin also resulted in the redistribution of HtrA from single foci (Fig. 4A ) to cells with multiple foci or a diffuse pattern (Fig. 4D ). Costaining with dansyl-polymyxin B ( Fig. 4B and E) revealed an overlap with HtrA foci in untreated cells (Fig. 4C ) and diffuse HtrA staining in gallidermin-treated cells (Fig. 4F) . These data suggest that interaction between gallidermin and lipid II promotes the disruption of ExPortal organization.
Gallidermin disrupts ExPortal-dependent secretion. Cationic antimicrobial peptides that disrupt the ExPortal can also inhibit the translocation of a subset of the toxins secreted by S. pyogenes (12) . Treatment with a nonlytic concentration of gallidermin also reduced the levels of the SpeB cysteine protease and the streptolysin O (SLO) cytolysin in culture supernatants, as revealed by Western blot analysis (Fig. 5) , similar to what has been observed with polymyxin B (12) . This inhibition was not the result of a generalized defect in protein secretion and synthesis because (i) cells remained viable (see Fig. S1 in the supplemental material), (ii) levels of SecA in gallidermin-exposed streptococci were unaltered relative to those in untreated bacteria ( (GFP) was unaffected in untreated and treated cultures when its expression was induced from a tetracycline-regulated promoter at the time of gallidermin or polymyxin B exposure, as assessed by Western blotting and fluorescence microscopy ( Fig. 5) . Altogether, these results indicate that the lipid II-targeting activity of a lantibiotic can disrupt ExPortal function in the absence of significant membrane damage. Several lipid II synthesis enzymes localize to membrane foci. Given the restriction of lipid II to sites of cell division and the high affinity of lantibiotics for the pyrophosphate moiety of lipid II, lantibiotic-lipid II interaction likely occurs in proximity to the membrane site where lipid II synthesis takes place (16) . To further examine whether peptidoglycan synthesis and ExPortal-mediated protein biogenesis are spatially coordinated processes, the localization of two enzymes involved in the membrane-associated steps of lipid II synthesis was monitored. MraY is a membraneintrinsic protein that catalyzes the transfer of the phospho-Nacetylmuramoyl (MurNAc) pentapeptide from the soluble cytoplasmic UDP-MurNAc pentapeptide substrate to the membraneembedded undecaprenyl-phosphate (C 55 -P) acceptor to produce undecaprenyl-pyrophosphoryl-MurNAc pentapeptide (lipid I) (15, 24) . MurN cycles between the cytoplasm and the inner leaflet of the membrane in order to attach L-alanine to the lipid II substrate. This represents the final synthetic step prior to the translocation of lipid II to the outer leaflet of the membrane (15, 24) . Strains for this analysis were constructed by modification of the native chromosomal loci in order to produce alleles that expressed proteins with C-terminal fusions to superfolder GFP (sfGFP). Since the genes encoding MraY and MurN are essential (25) and the modified alleles represent the only copy of each gene in the genome, the observation that the resulting strains were viable and had no growth rate defect indicates that the fusion proteins (MraY sfGFP , MurN sfGFP ) were fully functional. Consistent with their role in growth, peak expression of MraY sfGFP and MurN sfGFP occurred during the log phase of culture when examined by Western blotting (data not shown). When examined by fluorescence microscopy, MraY sfGFP localized to unique foci in the membrane, most prominently during log phase (Fig. 6A ). This focal pattern was confirmed when cells were examined by immunoelectron microscopy (Fig. 6A) . Similarly, MurN sfGFP also localized to unique foci when log-phase cells were examined by both fluorescence and immunoelectron microscopy (Fig. 6B) , although some localization throughout the cytoplasm was also observed. The focal localization of MraY and MurN contrasted with that of a fusion protein based on the membrane protein YajC, which demonstrated a uniform circumferential distribution when examined by fluorescence and electron microscopy ( Fig. 6C) that was unaltered by treatment with polymyxin B (Fig. 6F) . Finally, since it has been reported that fusion to a fluorescent partner can alter the localization patterns of certain proteins (26) , the localization of MurN was also examined following fusion to a small epitope tag (LFFF) developed for analysis of protein localization in streptococci (27) . Immunofluorescence microscopy demonstrated that MurN LFFF localized to unique focal sites (Fig. 6E ) in a pattern indistinguishable from that of an LFFF-tagged version of HtrA (Fig. 6D) .
MraY and MurN colocalize with the ExPortal. Since the pattern of localization of MraY and MurN resembled that of the ExPortal protein HtrA LFFF , it was of interest to determine if these lipid II enzymes also localize to the ExPortal. croscopy revealed that the localization of MraY (Fig. 7A to C) and MurN ( Fig. 7D to F) coincided with the focal site bound by dansylpolymyxin B (12) . Approximately 25 to 30% of the cells were observed to be colabeled, and Ͼ90% of these demonstrated coincident labeling (Fig. 7I) . Finally, the location of the lipid II synthetic enzymes was compared with that of SecA. Immunoelectron microscopy after costaining with antibodies conjugated to gold beads of different sizes revealed that the anti-SecA and antiMurN sfGFP conjugates recognized the same focal site on the streptococcal surface ( Fig. 7G and H) . These data indicate that synthesis of the peptidoglycan precursor and the site of polypeptide secretion are spatially coordinated.
DISCUSSION
The mechanism by which the cell wall supports ExPortal organization is unknown. However, the influence of the cell wall on lipid microdomains may be a feature shared with rod-shaped Grampositive bacteria. For example, in Bacillus subtilis, anionic phospholipids are organized into discrete microdomains that adopt a spiral configuration relative to the longitudinal cell axis (28, 29) . Removal of peptidoglycan or inhibition of lipid II synthesis results in the disruption of these spiral microdomains (30) . This suggests that either (i) peptidoglycan synthesis is necessary for the establishment of specific lipid microdomains in B. subtilis or (ii) disruption of lipid II production causes the disassembly of existing microdomains (30) . This also implies a link between the cell wall and protein secretion in B. subtilis, since it has also been shown that the anionic lipids are required for the organization of the Sec translocons into a longitudinal spiral pattern (31) . Segregation of anionic lipids may be a more general mechanism for organizing macromolecular complexes at membrane sites where their physiological activity is required. In Caulobacter crescentus, the organization of the cytoskeleton protein MreB to helical cables is dependent on lipid II (32) . Furthermore, the organization of the MinD cell division protein into a helical spiral pattern is dependent on phosphatidylglycerol (33) . Examination of cell wall synthesis in growing B. subtilis cells found that MreB and its isoforms assembled with cell wall synthesis holoenzyme components into discrete patches in the membrane that moved processively along peripheral tracks perpendicular to the cellular axis (34, 35) . The motility of these complexes was driven by cell wall synthesis, and the MreB polymers both restricted the localization of patch components and directed their movement (34, 35) . Together, these data point to a link between membrane lipid organization and the molecular machineries of peptidoglycan synthesis and cell division.
One mechanism by which peptidoglycan synthesis might influence membrane segregation is association of cytoskeletal components inside the cell with complexes for cell wall synthesis exterior to the membrane. This arrangement would place constraints on the distribution of anionic phospholipids in the intervening membrane in order to create and stabilize lipid microdomains. However, S. pyogenes lacks homologs to the cytoskeletal MreB proteins (6) and does not possess the synthetic machinery required for cell elongation, including RodA, MreC, and MreD (reviewed in reference 36). Rather, the macromolecular complex directing cell division and growth in S. pyogenes consists of the tubulin homologue FtsZ, several accessory divisome proteins (FtsA, FtsW, EzrA, DivIB, and DivIVA), and a set of high-and low-molecular-weight penicillin-binding proteins (36) . Thus, while both S. pyogenes and B. subtilis segregate anionic lipids into microdomains, the mechanisms underpinning how peptidoglycan synthesis and cell division are integrated with membrane structure are likely to be fundamentally different. Our examination of the localization of YajC also highlighted other fundamental differences from B. subtilis in the composition of the Sec protein export machinery itself. In B. subtilis, YajC is maintained at the membrane by its single transmembrane segment and is considered an auxiliary subunit of the Sec protein translocase by virtue of its coexpression and interaction with SecD and SecF, although it is nonessential for both viability and secretion (37). However, S. pyogenes does not possess either SecD or SecF (6) . Furthermore, exposure to polymyxin B at a concentration that alters anionic lipid and ExPortal structure did not alter the uniform distribution of YajC in the streptococcal membrane, suggesting that it is independent of the factors that influence ExPortal organization. Thus, the function of YajC in streptococci remains unknown.
In contrast to YajC, the localization of MraY and MurN may suggest a mechanism by which peptidoglycan can influence the formation of lipid microdomains. In model membranes, lipids can adopt various fluid and liquid-ordered phases, characterized by the different spatial arrangement and motional freedom of each lipid molecule with respect to the surrounding molecules (38) . Depending on composition, structure, and environment, different phases can coexist within a single membrane plane, resulting in lateral phase segregation and the formation of microdomains. The properties of these lipid phases can determine the orientation, mobility, and interaction of proteins and lipids and thus directly influence the biological functionality of the domains (39) . This suggests a role for the C 55 -P anchor of lipid II in organizing lipid microdomains. Spatial constraint of C 55 -P would create a microdomain of unique composition that may then direct the segregation of anionic lipids into microdomains. This mechanism would resemble how the spatial constraint of squalene/polyisoprenoid synthesis enzymes in B. subtilis acts to promote the formation of membrane microdomains with defined functionality (40) . Significantly, the C 55 -P membrane anchor of lipid II is a polyisoprenoid synthesized by the enzyme undecaprenyl pyrophosphate synthase (UppS) (41) . Thus, the localization of UppS, which in turn may involve the action of divisome proteins involved in determining the site of cell wall growth and septation, may be a key element promoting microdomain formation in S. pyogenes.
MATERIALS AND METHODS
Strains, media, and growth conditions. Experiments with S. pyogenes used strains HSC5 (M serotype 14) (42) and SF370 (M serotype 1) (6). For brevity, data presented are from HSC5 unless otherwise indicated, since identical results were obtained with both. For descriptions of these strains, see Table S3 in the supplemental material. Molecular cloning experiments used Escherichia coli DH5␣. Routine culture was at 37°C in Todd-Hewitt broth (BBL) supplemented with 0.2% yeast extract (Difco) (THY medium) for streptococci and LB medium for E. coli. Functional assays used cultures grown in C medium without agitation in closed containers for liquid medium or under anaerobic conditions with a commercial gas generator as described previously (43) . Antibiotics were used at the following concentrations for E. coli and S. pyogenes, respectively: kanamycin, 50 and 500 g/ml; spectinomycin, 100 and 100 g/ml; carbenicillin, 50 g/ml (E. coli only). In selected experiments, media were supplemented with polymyxin B (Sigma catalog number P0972-50MU), nisin (0.5 M; Sigma catalog number N5764), or gallidermin (1.0 M; a generous gift from James Smith, Texas A&M University) as described previously (12) .
DNA and protein techniques. Plasmid DNA was isolated via standard techniques and used to transform S. pyogenes or E. coli as described previously (44) . Restriction endonucleases, ligases, and polymerases were used according to the manufacturer's recommendations. The fidelity of all molecular constructs and mutated chromosomal loci was confirmed by PCR and determination of DNA sequences with oligonucleotide primers with the appropriate sequences. The concentrations of streptolysin O and the SpeB protease in culture supernatants and SecA in cell extracts were determined by Western blotting as described previously (12, 45) . Blots were developed with a Chemidoc XRS imager (Bio-Rad), and relative protein concentrations were determined with Quantity One software (version 4.6.7; Bio-Rad).
Fluorescent and epitope-tagged fusion proteins. Strains for expression of modified proteins were constructed by a standard recombinationbased method (see Text S1 in the supplemental material). In the resulting strains, native chromosomal loci were modified to express hybrid proteins fused at their C termini to sfGFP (46) , a hemagglutinin (HA) epitope tag (11) , or the LFFF epitope tag (27) . In each strain, the modified gene represents the only copy of that gene in the genome. For the primers and plasmids used in strain construction and for the resulting strains, see Tables S1 to S3 in the supplemental material.
Preparation of protoplasts. Peptidoglycan was digested with PlyC, a lysin enzyme with activity against the cell wall of S. pyogenes, prepared as described previously (47, 48) . Protoplasts were generated by treatment with PlyC (5 U/ml, 10 min) in 30% (wt/vol) raffinose solution supplemented with 5 mM EDTA as described previously (47, 48) . For visualization of lipid and protein localization, protoplasts were resuspended in either ThyB or C medium supplemented with 5 to 8% glycerol, as indicated in Results. Fluorescence microscopy. Intact streptococci, protoplasts, or streptococci from cultures challenged with polymyxin B or lantibiotics were stained with sublethal concentrations of dansyl-polymyxin B (10 M; Invitrogen catalog number P13238) or polymyxin B-BODIPYFL conjugate (10 or 60 M; Invitrogen catalog number P13235) as described previously (12) . Samples were examined with a Leica DM IRE2 fluorescence microscope, and images were captured with a QImaging Retiga 1350 EX charged-coupled device camera and Openlab software (Improvision). Where indicated, cell walls were visualized by staining with fluorescent vancomycin (1 g/ml; Invitrogen catalog number V34850) or WGA conjugated to Alexa Fluor 488 or 350 (5 g/ml; Invitrogen catalog number W11261 or W11263) and neutral membrane lipids were visualized by staining with Nile Red (2.5 g/ml; Invitrogen catalog number N1142). Cellular viability was assessed by staining with a fluorescent vital dye (LIVE/DEAD, BacLight; Invitrogen) (12) and is described in detail in Text S1 in the supplemental material.
Immunofluorescence and immunogold microscopy. Streptococcal cells from untreated or various treated cultures were processed with PlyC and fixed as described previously (9) . Immunofluorescence microscopy to detect HtrA-HA and SecA was conducted as described previously (3, 11) . Other antisera included a polyclonal rabbit anti-FLAG antibody (Sigma F7425) used at a dilution of 1:250 and detected with Alexa Fluor 488-labeled goat anti-rabbit IgG (Invitrogen) diluted 1:500. Cell walls were stained with WGA-Alexa Fluor 350 (Invitrogen) as described above. Slides were mounted in an antifade reagent (ProLong Gold; Invitrogen), and images were captured as described above. For immunogold electron microscopy, samples were harvested from the early or mid-logarithmic phase of growth and processed as described previously (3, 11) . Colocalization studies used a polyclonal rabbit anti-GFP antibody (ab6556; Abcam) at a dilution of 1:100. Sections were stained with streptavidin-gold conjugates with beads of the various sizes indicated in the figure legends (BBI International) and examined by electron microscopy as previously detailed (3, 11) .
Images and quantitative and statistical analyses. Images were processed for publication with Adobe Photoshop CS and represent spliced montages representative of multiple stained cells. Quantitation of foci was performed as described in detail elsewhere (2) . The data presented are means and standard error of the means derived from at least three independent experiments consisting of the examination of a minimum of 1,000 stained cells for each experimental condition. Differences between mean values were tested for significance with a two-tailed Student t test, and the null hypothesis was rejected for P values of Ͻ0.05.
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